Precision System Science Co., Ltd. (7707) Cash flow
Market cap
¥6.1B
P/E ratio
52x
Precision System Science develops and manufactures laboratory automation equipment and genetic testing instruments for life sciences, serving universities, research institutions, and pharmaceutical companies worldwide.
| 2014/06 | 2015/06 | 2016/06 | 2017/06 | 2018/06 | 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Depreciation & amortization | 221 | 286 | 286 | 104 | 83 | 86 | 122 | 374 | 535 | 641 | 409 | 238 |
| Cash from operations | -823 | -1,363 | 72 | -803 | -33 | -404 | -21 | -281 | 869 | -7 | -107 | 96 |
| Capital expenditures | -602 | -205 | -266 | -257 | -109 | -90 | -208 | -1,666 | -1,956 | -135 | -12 | -53 |
| Cash from investing | 4,706 | -150 | -260 | -268 | -116 | -95 | -214 | -1,813 | -2,285 | -214 | 2,057 | -8 |
| Payments for dividends | -206 | -136 | -0 | -0 | -0 | - | - | - | -138 | - | - | - |
| Repurchases of common stock | - | - | - | - | - | - | -0 | - | -100 | -0 | -0 | -100 |
| Proceeds from issuance of term debt, net | 500 | 630 | 250 | 400 | 100 | 100 | 300 | 1,198 | 1,739 | 600 | - | - |
| Repayments of term debt | -635 | -686 | -486 | -413 | -335 | -334 | -267 | -224 | -306 | -453 | -2,500 | -502 |
| Cash from financing | -2,646 | 175 | 1,124 | 828 | -237 | 309 | 511 | 4,002 | 94 | -154 | -2,508 | -911 |
| Free cash flow | ||||||||||||
| FCF margin (%) |